文献速递系统性红斑狼疮

系统性红斑狼疮出院后随访与急性医疗使用及死亡率的关联:一项Medicare队列研究

Associations of Postdischarge Follow-Up With Acute Care and Mortality in Lupus: A Medicare Cohort Study.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2023-03-08

该观察性队列研究纳入2014年1月至11月20%随机抽样的Medicare成人狼疮住院患者,检验弱势人群随访完成率更低及随访预测无急性医疗使用或死亡时间更长的假说。结果显示35%住院缺乏30天随访,年轻、弱势社区及农村居民随访几率更低;在65岁及以上患者中随访与急性医疗使用风险升高相关(调整HR 1.27),但与死亡率降低65%相关(调整HR 0.35)。

要点

  • 35%的狼疮住院在出院后30天内缺乏随访。
  • 年轻、居住于弱势社区及农村与随访几率更低相关。
  • 65岁及以上患者中随访与急性医疗使用风险升高及死亡率降低相关。

核心结论

  • 约三分之一狼疮住院缺乏随访,农村及弱势社区存在显著差异。
  • 在老年系统性红斑狼疮患者中,随访与急性医疗使用增加相关,但与死亡率降低65%相关。
  • 需要进一步制定狼疮特异性出院后策略。

研究设计与样本

  • 观察性队列研究,纳入2014年1月至11月20%随机抽样的Medicare成人狼疮住院,出院回家非临终关怀且住院前后有连续Medicare A/B覆盖。
  • 及时随访定义为出院后30天内初级保健或风湿科就诊。
  • 30天生存结局为急性医疗使用和死亡率,并针对社会人口学信息和合并症进行调整。

主要发现

  • 超过三分之一(35%)的狼疮住院缺乏30天随访。
  • 年轻年龄、居住于弱势社区和农村与随访几率更低相关。
  • 在65岁以下受益人,随访与后续急性医疗使用或死亡率无显著关联。
  • 在65岁及以上受益人,随访与急性医疗使用风险升高27%相关(调整HR 1.27 [95%CI 1.09-1.47])。
  • 在65岁及以上受益人,随访与死亡率降低65%相关(调整HR 0.35 [95%CI 0.19-0.67])。

局限性

  • 需要进一步制定狼疮特异性出院后策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with systemic lupus erythematosus experience the sixth highest rate of 30-day readmissions among chronic diseases. Timely postdischarge follow-up is a marker of ambulatory care quality that can reduce readmissions in other chronic conditions. Our objective was to test the hypotheses that 1) beneficiaries from populations experiencing health disparities, including patients from disadvantaged neighborhoods, will have lower odds of completed follow-up, and that 2) follow-up will predict longer time without acute care use (readmission, observation stay, or emergency department visit) or mortality. METHODS: This observational cohort study included hospitalizations in January-November 2014 from a 20% random sample of Medicare adults. Included hospitalizations had a lupus code, discharge to home without hospice, and continuous Medicare A/B coverage for 1 year before and 1 month after hospitalization. Timely follow-up included visits with primary care or rheumatology within 30 days. Thirty-day survival outcomes were acute care use and mortality adjusted for sociodemographic information and comorbidities. RESULTS: Over one-third (35%) of lupus hospitalizations lacked 30-day follow-up. Younger age, living in disadvantaged neighborhoods, and rurality were associated with lower odds of follow-up. Follow-up was not associated with subsequent acute care or mortality in beneficiaries age <65 years. In contrast, follow-up was associated with a 27% higher hazard for acute care use (adjusted hazard ratio [HR] 1.27 [95% confidence interval (95% CI) 1.09-1.47]) and 65% lower mortality (adjusted HR 0.35 [95% CI 0.19-0.67]) among beneficiaries age ≥65 years. CONCLUSION: One-third of lupus hospitalizations lacked follow-up, with significant disparities in rural and disadvantaged neighborhoods. Follow-up was associated with increased acute care, but 65% lower mortality in older systemic lupus erythematosus patients. Further development of lupus-specific postdischarge strategies is needed.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Schletzbaum M, Sweet N, Astor B, et al. Associations of Postdischarge Follow-Up With Acute Care and Mortality in Lupus: A Medicare Cohort Study. Arthritis Care Res (Hoboken). 2023. PMID: 36752354. doi:10.1002/acr.25097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。